A Study Assessing Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise



Status:Completed
Conditions:Diabetes
Therapuetic Areas:Endocrinology
Healthy:No
Age Range:18 - 70
Updated:10/14/2017
Start Date:September 2006
End Date:December 2009

Use our guide to learn which trials are right for you!

Mechanism of Action and Efficacy of Saxagliptin (BMS-477118) in the Treatment of Type 2 Diabetic Patients

The purpose of this clinical research study is to learn whether Saxagliptin can improve the
body's ability to make its own insulin and lower blood sugar in people with type 2 diabetes

All subjects will participate in a lead-in period, and qualifying subjects will continue into
a short-term randomized treatment period. Subjects who complete the short-term period will be
eligible to enter the long term extension period. Also, subjects who have an elevated blood
sugar that requires additional medication for blood sugar control will be eligible to receive
open-label metformin added onto their blinded study medication

Inclusion Criteria:

- Type 2 diabetes mellitus

- Drug naive

- Hemoglobin A1c (HbA1c) ≥6.0% and ≤8.0%

- Fasting C-peptide ≥1.0 ng/mL

- Body mass index ≤40 kg/m²

Exclusion Criteria:

- Recent cardiac or cerebrovascular event

- Elevated serum creatinine
We found this trial at
3
sites
3350 La Jolla Village Dr
San Diego, California 92161
(858) 552-8585
VA San Diego Healthcare System The VA San Diego Healthcare System (VASDHS) provides high quality...
?
mi
from
San Diego, CA
Click here to add this to my saved trials
6400 Perkins Rd
Baton Rouge, Louisiana 70808
(225) 763-2500
Pennington Biomedical Research Center Unlike other medical research facilities where science occurs in separate labs...
?
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
?
mi
from
San Antonio, TX
Click here to add this to my saved trials